UK markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
79.83+0.62 (+0.78%)
At close: 4:02PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5201.91B
Enterprise value 3221.77B
Trailing P/E 19.45
Forward P/E 112.61
PEG ratio (5-yr expected) 12.11
Price/sales (ttm)4.28
Price/book (mrq)7.30
Enterprise value/revenue 34.70
Enterprise value/EBITDA 611.64

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3-2.88%
S&P500 52-week change 314.01%
52-week high 392.64
52-week low 365.25
50-day moving average 381.94
200-day moving average 380.54

Share statistics

Avg vol (3-month) 37.96M
Avg vol (10-day) 38.24M
Shares outstanding 52.53B
Float 2.53B
% held by insiders 10.08%
% held by institutions 178.55%
Shares short (29 Sep 2020) 410.98M
Short ratio (29 Sep 2020) 41.29
Short % of float (29 Sep 2020) 40.43%
Short % of shares outstanding (29 Sep 2020) 40.43%
Shares short (prior month 30 Aug 2020) 412.11M

Dividends & splits

Forward annual dividend rate 42.44
Forward annual dividend yield 43.06%
Trailing annual dividend rate 32.32
Trailing annual dividend yield 32.93%
5-year average dividend yield 42.96
Payout ratio 457.91%
Dividend date 306 Oct 2020
Ex-dividend date 413 Sep 2020
Last split factor 22:1
Last split date 316 Feb 1999

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin 22.20%
Operating margin (ttm)33.10%

Management effectiveness

Return on assets (ttm)11.19%
Return on equity (ttm)37.85%

Income statement

Revenue (ttm)47.19B
Revenue per share (ttm)18.57
Quarterly revenue growth (yoy)-7.60%
Gross profit (ttm)33.68B
EBITDA 19.05B
Net income avi to common (ttm)10.48B
Diluted EPS (ttm)4.10
Quarterly earnings growth (yoy)12.40%

Balance sheet

Total cash (mrq)11.11B
Total cash per share (mrq)4.39
Total debt (mrq)30.87B
Total debt/equity (mrq)111.28
Current ratio (mrq)1.32
Book value per share (mrq)10.93

Cash flow statement

Operating cash flow (ttm)13.09B
Levered free cash flow (ttm)9.74B